Cantitate/Preț
Produs

Misfolding of Amyloid-beta and tau in Alzheimer’s and Other Neurodegenerative Diseases

Autor Louise Serpell
en Limba Engleză Hardback – 31 dec 2024
Misfolding of Amyloid-beta and tau in Alzheimer’s and Other Neurodegenerative Diseases describes historical discoveries of these two major proteins in Alzheimer’s disease and other neurodegenerative conditions. The book navigates through the importance of protein self-assembly, protein conformational change, and structural studies in understanding the positioning in the disease pathway. How these proteins are involved in the pathway to neuronal dysfunction, and the importance of understanding protein conformation and deposition for diagnosis are also highlighted. Although Alzheimer’s disease was discovered over 100 years ago, the role of protein misfolding in the pathology and cause of Alzheimer’s disease remains unclear. Amyloid-beta and Tau are both proteins well known for their involvement in Alzheimer’s disease. Both proteins misfolding and aggregate are deposited as cross-beta amyloid fibrils in the tissues.

  • Focuses on structural biology and the cellular effects leading to Alzheimer’s and other neurodegenerative diseases
  • Answers the question, how do Amyloid beta and tau influence one another?
  • Discusses the Kinetics, conformational change, role of sequence, and mutations of Amyloid-beta and tau
Citește tot Restrânge

Preț: 67255 lei

Preț vechi: 73906 lei
-9% Nou

Puncte Express: 1009

Preț estimativ în valută:
12870 13356$ 10758£

Carte nepublicată încă

Doresc să fiu notificat când acest titlu va fi disponibil:

Preluare comenzi: 021 569.72.76

Specificații

ISBN-13: 9780323992688
ISBN-10: 0323992684
Pagini: 300
Dimensiuni: 151 x 229 mm
Editura: ELSEVIER SCIENCE

Cuprins

1. Historical perspective: introduction to the discovery of pathological proteins deposited in Alzheimer’s disease
2. Genetics of Alzheimer’s disease and the generation of Amyloid beta
3. Genetics of tauopathies
4. Self-assembly of Amyloid-beta and tau (Kinetics, conformational change, role of sequence, mutations)
5. Structure of amyloid fibrils formed by Amyloid-beta and tau: latest perspectives from CryoEM and what has led up to its contribution
6. The role of amyloid beta and tau in disease: how might oligomers and fibrils affect neuronal health and physiological health in humans
7. Therapeutics that target amyloid beta and tau generation and aggregation
8. Diagnostics: using the deposition and conformational status of Amyloid beta and tau for diagnosis (MRI; CSF analysis and Prion seeding assays)
9. Interaction: how do Amyloid beta and tau influence one another?
10. Other proteins: the contribution of ApoE genotype to amyloid and tau aggregation and clearance
11. Other proteins: The role of chaperone system in disease: proteostasis and disease
12. Future perspectives: what the future holds and where will research go next?